Roux-en-Y gastric bypass (RYGB) surgery potently improves obesity and a myriad of obesity-associated co-morbidities including type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). Time-series omics data are increasingly being utilized to provide insight into the mechanistic underpinnings that correspond to metabolic adaptations in RYGB. However, the conventional computational biology methods used to interpret these temporal multi-dimensional datasets have been generally limited to pathway enrichment analysis (PEA) of isolated pair-wise comparisons based on either experimental condition or time point, neither of which adequately capture responses to perturbations that span multiple time scales. To address this, we have developed a novel graph network-based analysis workflow designed to identify modules enriched with biomolecules that share common dynamic profiles, where the network is constructed from all known biological interactions available through the Kyoto Encyclopedia of Genes and Genomes (KEGG) resource. This methodology was applied to time-series RNAseq transcriptomics data collected on rodent liver samples following RYGB, and those of sham-operated and weight-matched control groups, to elucidate the molecular pathways involved in the improvement of as NAFLD. We report several network modules exhibiting a statistically significant enrichment of genes whose expression trends capture acute-phase as well as long term physiological responses to RYGB in a single analysis. Of note, we found the HIF1 and P53 signaling cascades to be associated with the immediate and the long-term response to RYGB, respectively. The discovery of less intuitive network modules that may have gone overlooked with conventional PEA techniques provides a framework for identifying novel drug targets for NAFLD and other metabolic syndrome co-morbidities.
Skin organoids have evolved into versatile models, including reconstructed epidermis, skin equivalents, and composite organoids with appendages. Despite this progress, a unified framework linking construction approaches with developmental outcomes and experimental value remains needed. This review summarizes key determinants of organoid construction: cell source, assembly methods, extracellular matrix, precise signaling control, and quality assessment. It addresses how these factors shape developmental complexity, reproducibility, and scalability, guiding model selection. Advances in engineering, such as air– liquid interface culture and three-dimensional bioprinting, are highlighted for their potential to improve tissue structure and function. By outlining stage-specific evaluation and practical optimization strategies, this review provides a foundation for standardized protocols and the future development of physiologically relevant skin organoid systems for research and clinical applications.